The Green Organic Dutchman (TGOD)
Farm Grown – Pharma Grade Organic Cannabis Product
As the 3rd LP backed by the same financial team that brought together OrganiGram and Emblem Cannabis, Green Organic Dutchman grows the highest quality Organic medical cannabis in small batches using craft growing, all natural and organic principles. With experienced, passionate growers with over 8 years of MMAR growing experience, 25 acres of land, and immediate revenue from wholesale market, Green Organic Dutchman expects to generate $90 million by 2018.
Phase 1 Facility Expansion Already Underway
Production license received on 8/17/16
1,000 kg annual operating capacity
Wholesale contract agreements in place
25 acres of potential facility footprint
Level 8 Vault holding up to 625Kg
Phase 1 expansion ready to commence
Licensed to Produce by Health Canada as of Aug 17, 2016
Green Organic Dutchman is licensed under the access to cannabis for medical purposes regulations (ACMPR) to cultivate medical marijuana. Green Organic carries out its principal activities producing marijuana from its facilities in Ancaster, Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.
3 Pillar Marketing Strategy
- Significant demand from fellow LP’s for
- Forward sale agreements allow for
immediate revenue in early stages of
development while retail following is
- No fulfillment and minimal shipping
- Wholesale platform operates at high
margin with low overhead
- As patient acquisitions increase and as
recreational market comes on line,
sales will shift from wholesale to
much more profitable
- Patients demand quality and pay a
premium price for organic product
over irradiated products
- Developing Strategic partnerships
with marijuana clinic networks, pain
clinics, and veteran networks
- In discussion with significant
distribution partners: LPs, drug
stores, pharma companies, liquor
stores, & dispensaries for
- Creates instant distribution to the
much more profitable
- Management team has significant
experience in structuring
large JV transactions
Proven and Experienced Leadership Team
Backed by the financing team behind OrganiGram and Emblem Cannabis
Chairman of the Board – Green Organic Dutchman
Mr. Paikin is the president and founder of New Horizon Development Group. In 2013 he was named RBC Distinguished Citizen of the Year for Hamilton. He is very active in the home building industry as a past president of the Hamilton Halton Home Builders’ Association and a former board member of both the Ontario Home Builders’ Association and the Canadian Home Builders’ Association. Jeff is a member of the Hamilton Tiger- Cats advisory board and the Hamilton Bulldogs Community Foundation board, as well as being the current Chair of the Hillfield Strathallan College Capital Campaign and past Chair of the board of both Hillfield Strathallan College and the Canadian Accredited Independent Schools (CAIS.ca).
CEO & Director – Green Organic Dutchman
Mr. Anderson brings 20 years of experience working with micro-cap companies in a broad range of sectors. Having spent 12 years in the Canadian brokerage Industry with one of Canada’s leading independent firms, and having financed hundreds of micro-cap companies he has an impressive track record of success, with multiple companies reaching market valuations in excess of $1B. Mr. Anderson is a strong advocate for retail shareholders, believes in a staged financing to address a company’s capital requirements, as well as advising on the development of business plans, recruiting management, negotiating transactions, joint ventures, and supporting management during the company’s growth cycle. Value of Investment into Green Organic Dutchman: $1,000,000.
Co-founder, Director & COO – Green Organic Dutchman
Mr. Skinner is a cofounder and COO of The Green Organic Dutchman. Scott engineered, designed and oversaw the construction of the Green Organic Dutchman’s production facility. This state-of-the-art facility now houses over 35 varieties of Cannabis. Scott’s current ongoing projects are the research and development of LED based Light Spectrum Optimization Technology for best cannabis production yields along with the development of Tissue Culture Propagation Protocols for the rapid cloning of cannabis plants.
Director – Green Organic Dutchman
Mr. Doherty brings over 20 years of investment and finance experience to the company. Mr. Doherty was an investment adviser with Canaccord Capital, Canada’s largest independent securities dealer covering the North American capital markets specializing in developing, structuring and financing venture and growth companies in the Resource sector. Mr. Doherty has sat on numerous boards including Organigram Holdings and presently is on the Board of Saber Capital, to be renamed Emblem Cannabis. He holds a degree from Simon Fraser University, with a major in finance. Value of Investment into Green Organic Dutchman: $900,000.
President – Green Organic Dutchman
Mr. Cernovitch brings over 20 years of investment and corporate finance experience to the company. Marc studied Economics at McGill University and has focused on corporate development, funding and building companies primarily in the resource and energy technology fields. He has a strong background in corporate governance and finance. For the past 20 years, Mr. Cernovitch has been providing capital markets advisory services to companies across both public & private sectors. In this capacity, Mr. Cernovitch has served as a director and advisor to numerous small and mid-cap companies contemplating and/or executing financing and M&A transactions. Value of Investment into Green Organic Dutchman: $600,000.
Co-founder – Green Organic Dutchman
Mrs. Vandermarel grew up on a commercial scale fruit farm in Southern Ontario and learned about agricultural business management. Jeannette’s daughter Breanne passed away in 2003 as a result of Dravet Syndrome, a severe seizure disorder. Breanne spent most of her 8 years of life on powerful anticonvulsant drugs that did little to control her seizures and unfortunately caused serious side effects. She was never given cannabis. Around 2008, anecdotal reports began showing potential for cannabis based medicines. Jeannette, while caring for children with severe seizures in the Paediatric ICU became aware that some children were having great seizure control by using cannabis medicines.